 | Join Alive! Maryland for a Three-Part
Harm Reduction Webinar Series! August 29, 30, and 31, 2022 |
| | Harm Reduction Psychotherapy
Parts 1 and 2 Integrative Harm Reduction Psychotherapy (IHRP) is an innovative treatment for people who use substances. Unlike the traditional disease model of addiction, harm reduction psychotherapy uses a biopsychosocial approach to understand the complexities of problematic drug use and addiction. This 2-part webinar will take place on August 29 at 1:00pm EDT and August 30 at 1:00pm EDT. Topics explored will include: - Introduction to Harm Reduction Psychotherapy and IHRP
- Overview of 7 therapeutic tasks of IHRP
- Discussion of harm reduction principles and practices
- Clinical challenges in conceptualizing and treating addictive behaviors
- Scientific revolution / paradigm change and compassionate pragmatism
Continuing education credits are available for this webinar, pending accreditation. |
| Part 1: August 29, 2022 at 1:00pm EDT |
| |
|
Part 2: August 30, 2022 at 1:00pm EDT |
| |
|
|
|
| About the Faculty: Andrew Tatarsky, PhD |
|  | Andrew Tatarsky has worked with people who struggle with drugs for over 40 years. He developed Integrative Harm Reduction Psychotherapy (IHRP) for treating the spectrum of risky and addictive behavior as an alternative to traditional abstinence-only substance use treatment. IHRP brings relational psychoanalysis, CBT, and mindfulness together in a harm reduction frame. Dr. Tatarsky holds a doctorate in clinical psychology from the City University of New York and is a graduate of New York University’s Postdoctoral Program in Psychoanalysis and Psychotherapy. He is the Founder and Director of the Center for Optimal Living in NYC, a treatment, education, and professional training center based on IHRP. |
|
|
| | Injection Drug Use: Wound and Skin Changes Skin infection in people who inject drugs (PWID) poses significant risks, including endocarditis, septicemia, and necrotizing fasciitis, which increase morbidity and healthcare costs for this population. To prevent the progression and spread of wounds in PWID, providers must be educated on the complications of drug use in this population and create trusting relationships with PWID to ensure engagement in care. This webinar will take place on August 31 at 1:00pm EDT. Topics explored will include: - Skin and wound changes in people who inject drugs
- Physical and psychosocial issues affecting wound care
Continuing education credits are available for this webinar, pending accreditation. |
| August 31, 2022 at 1:00pm EDT |
| | About the Faculty: Barbara Ann Datres Pieper, PhD, RN, CWOCN, ACNS-BC, FAAN |
|  | Barbara Ann Datres Pieper is a retired nurse practitioner and professor who taught at Wayne State School of Nursing for 40 years. Her clinical expertise and research is focused on Wound Ostomy Continence (WOC). |
|
|
| |
|
| | Contact: Melissa Kelley, Alive! Maryland Project Director, at [email protected] with questions. |
| | About Alive! Maryland The Maryland Department of Health engaged with HealthHIV, a national capacity building organization, to launch Alive! Maryland, the first-ever comprehensive capacity building initiative for the infectious disease and primary care workforce in the State of Maryland. ALIVE! stands for Assess, Learn, Integrate, Visualize, Engage — representing each phase of the program. Alive! Maryland is a motivational call to action to build capacity to improve health in Maryland’s HIV, viral hepatitis, STIs, and harm reduction workforce. This initiative will provide Maryland providers with a web-based, self-paced Virtual Training Institute, many CEU opportunities, direct training and technical assistance, resource development, and more. All resources, trainings, and tools are housed on a user-friendly and accessible website for Maryland’s infectious disease and primary care workforce. Visit AliveMaryland.org for more information. |
|
|
|
|
| |  | HealthHIV
1630 Connecticut Ave., NW Suite 500 | Washington, District of Columbia 20009
202-232-6749 | [email protected] |
| |
|
| |
|
| |
|
|
